We are live on
!
Find out more
PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
1-Year Est. Return
121.41%
This Fund
S&P 500
This Quarter
Est. Return
-8.58%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$2.33M
(+1.9%)
Cap. Flow
+$17.7M
Cap. Flow
% of AUM
14.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dare Bioscience
DARE
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$3.45M |
| 2 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$34K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.33% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |
Similar funds
IFC
AG
RCM
IR
CCM
EIP
AAM
OEP
Polaris Venture Management Co V's Q2 2014 Portfolio in Review
As of Q2 2014, Polaris Venture Management Co V held 7 positions worth $123M, up 1.9% from $120M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Polaris Venture Management Co V deployed $17.7M of net new capital in Q2 2014, opening 1 new position. Its largest new stake was Dare Bioscience: 27,396 shares worth $19.1M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the most notable exit was Twitter, Inc., an estimated $3.45M sold.
- Polaris Venture Management Co V's largest Q2 2014 buy was Dare Bioscience: 27,396 shares worth $19.1M.
- Polaris Venture Management Co V fully exited Twitter, Inc. in Q2 2014, selling an estimated $3.45M.
- Polaris Venture Management Co V's ten largest holdings make up 100% of its $123M portfolio in Q2 2014.
- Polaris Venture Management Co V opened 1 new position and closed 2 in Q2 2014.
- Polaris Venture Management Co V's portfolio value rose 1.9% quarter-over-quarter to $123M.
Based on Polaris Venture Management Co V's 13F filing for Q2 2014, filed 11 Aug 2014.